ZA977766B - Tablet with controlled release of alfuzosin hydrochloride. - Google Patents

Tablet with controlled release of alfuzosin hydrochloride.

Info

Publication number
ZA977766B
ZA977766B ZA9707766A ZA977766A ZA977766B ZA 977766 B ZA977766 B ZA 977766B ZA 9707766 A ZA9707766 A ZA 9707766A ZA 977766 A ZA977766 A ZA 977766A ZA 977766 B ZA977766 B ZA 977766B
Authority
ZA
South Africa
Prior art keywords
tablet
controlled release
alfuzosin hydrochloride
alfuzosin
hydrochloride
Prior art date
Application number
ZA9707766A
Inventor
Lauretta Maggi
Ubaldo Conte
Pascal Grenier
Guy Vergnault
Alain Dufour
Francois Xavier Jarreau
Clemence Rauch-Desanti
Original Assignee
Sanofi Synthalabo
Jagotek Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthalabo, Jagotek Ag filed Critical Sanofi Synthalabo
Publication of ZA977766B publication Critical patent/ZA977766B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
ZA9707766A 1996-08-29 1997-08-28 Tablet with controlled release of alfuzosin hydrochloride. ZA977766B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610551A FR2752737B1 (en) 1996-08-29 1996-08-29 CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE

Publications (1)

Publication Number Publication Date
ZA977766B true ZA977766B (en) 1998-02-23

Family

ID=9495273

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707766A ZA977766B (en) 1996-08-29 1997-08-28 Tablet with controlled release of alfuzosin hydrochloride.

Country Status (2)

Country Link
FR (1) FR2752737B1 (en)
ZA (1) ZA977766B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
ITMI20050391A1 (en) * 2005-03-11 2006-09-12 Ph & T S P A CONTROLLED RELEASE FORMULATIONS OF ALFUZOSIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2582513B1 (en) * 1985-05-28 1988-08-05 Synthelabo PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
FR2717388B1 (en) * 1994-03-21 1996-11-22 Synthelabo Extended release dosage forms of alfuzosin hydrochloride.

Also Published As

Publication number Publication date
FR2752737A1 (en) 1998-03-06
FR2752737B1 (en) 1998-10-02

Similar Documents

Publication Publication Date Title
IL128146A0 (en) Tablet with controlled release of alfuzosin hydrochloride
AU3406497A (en) Controlled release tablet
ZA200108291B (en) Diaminothiazoles and their use for inhibiting protein kinases.
PT1061906E (en) Monolithic tablet for controlled drug release
ZA98362B (en) 3-heterocyclyl-substituted benzoyl derivatives.
ZA978512B (en) Olanzapine dihydrate D.
EP0608897A3 (en) Tyrosine kinase inhibitors and benzoylacrylamide derivatives.
ZA987844B (en) Therapeutic combinations.
ZA200101762B (en) Immediate release tablet.
ZA9811339B (en) Benzamidine derivatives.
ZA971869B (en) Implants with phasewise release of pharmaceutical substance.
DE69625189D1 (en) CONTROLLED RELEASE TABLET
ZA978045B (en) New benzamidine derivatives.
AU141186S (en) Tablet
PL354994A1 (en) Bio-supportive matrices, methods of making and using the same
GB9714971D0 (en) Assays,therapeutic methods and means
ZA986273B (en) Purine derivatives and the use for medicine thereof.
ZA977766B (en) Tablet with controlled release of alfuzosin hydrochloride.
ZA963620B (en) (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use.
AU133610S (en) Tablet
CA80217S (en) Tablet
CA80449S (en) Tablet
CA80450S (en) Tablet
IL117677A0 (en) Controlled release tablets
ZA200108752B (en) Expansible closure and structural member for use therein.